Skip to content
Agentic OS
Menu

Intelligence / Healthtech / New Clinical Trials / REMD Medical Technology

Clinicaltrial registered4 Nov 2026

REMD Medical Technology

4 Nov 2026: Trial registered · A Study of the Safety and Effectiveness of a Compound Steep-Pulse Therapy Apparatus for Malignant Liver Tumors. Recorded in the ClinicalTrials.gov (US National Library of Medicine).

View the source record

Posted
4 Nov 2026
Title
A Study of the Safety and Effectiveness of a Compound Steep-Pulse Therapy Apparatus for Malignant Liver Tumors
Conditions
Malignant Liver Tumors
Phase
Not applicable
Study Type
Interventional
Status
Completed
Countries
China
Country
China
Reference
NCT07916350
Location
China
What this signal means

A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.

  1. United States leads with 192 of 777, then China (171).
  2. 777 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at REMD Medical Technology

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this clinical signal, for your approval.

Start free

More from China

New Clinical Trials

See all

Source: ClinicalTrials.gov (US National Library of Medicine), data to 18 Nov 2026. Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase. AOS shows what the public record says; it does not verify or endorse the company.